These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 31084498

  • 1. Neuropeptide 26RFa (QRFP) is a key regulator of glucose homeostasis and its activity is markedly altered in obese/hyperglycemic mice.
    Prévost G, Arabo A, Le Solliec MA, Bons J, Picot M, Maucotel J, Berrahmoune H, El Mehdi M, Cherifi S, Benani A, Nédélec E, Coëffier M, Leprince J, Nordqvist A, Brunel V, Déchelotte P, Lefebvre H, Anouar Y, Chartrel N.
    Am J Physiol Endocrinol Metab; 2019 Jul 01; 317(1):E147-E157. PubMed ID: 31084498
    [Abstract] [Full Text] [Related]

  • 2. The 26RFa (QRFP)/GPR103 neuropeptidergic system in mice relays insulin signalling into the brain to regulate glucose homeostasis.
    El Mehdi M, Takhlidjt S, Devère M, Arabo A, Le Solliec MA, Maucotel J, Bénani A, Nedelec E, Duparc C, Lefranc B, Leprince J, Anouar Y, Prévost G, Chartrel N, Picot M.
    Diabetologia; 2022 Jul 01; 65(7):1198-1211. PubMed ID: 35476025
    [Abstract] [Full Text] [Related]

  • 3. Hypothalamic Neuropeptide 26RFa Acts as an Incretin to Regulate Glucose Homeostasis.
    Prévost G, Jeandel L, Arabo A, Coëffier M, El Ouahli M, Picot M, Alexandre D, Gobet F, Leprince J, Berrahmoune H, Déchelotte P, Malagon M, Bonner C, Kerr-Conte J, Chigr F, Lefebvre H, Anouar Y, Chartrel N.
    Diabetes; 2015 Aug 01; 64(8):2805-16. PubMed ID: 25858563
    [Abstract] [Full Text] [Related]

  • 4. [The neuropeptide 26RFa and its role in the regulation of energy metabolism].
    Chartrel N, Prévost G, El Medhi M, Arabo A, Berrahmoune H, Maucotel J, Anouar Y, Picot M.
    Biol Aujourdhui; 2016 Aug 01; 210(4):227-235. PubMed ID: 28327281
    [Abstract] [Full Text] [Related]

  • 5. Interactions between the regulatory peptide 26RFa (QRFP) and insulin in the regulation of glucose homeostasis in two complementary models: The high fat 26RFa-deficient mice and the streptozotocin insulin-deficient mice.
    Le Solliec MA, Arabo A, Takhlidjt S, Maucotel J, Devère M, Berrahmoune H, Bénani A, Nedelec E, Lefranc B, Leprince J, Picot M, Chartrel N, Prévost G.
    Neuropeptides; 2023 Apr 01; 98():102326. PubMed ID: 36791581
    [Abstract] [Full Text] [Related]

  • 6. Acute but Not Chronic Central Administration of the Neuropeptide 26RFa (QRFP) Improves Glucose Homeostasis in Obese/Diabetic Mice.
    Le Solliec MA, Arabo A, Takhlidjt S, Maucotel J, Devère M, Riancho J, Berrahmoune H, do Rego JL, do Rego JC, Bénani A, Nedelec E, Lefranc B, Leprince J, Anouar Y, Picot M, Chartrel N, Prévost G.
    Neuroendocrinology; 2022 Apr 01; 112(11):1104-1115. PubMed ID: 35093951
    [Abstract] [Full Text] [Related]

  • 7. Glucose homeostasis is impaired in mice deficient in the neuropeptide 26RFa (QRFP).
    El-Mehdi M, Takhlidjt S, Khiar F, Prévost G, do Rego JL, do Rego JC, Benani A, Nedelec E, Godefroy D, Arabo A, Lefranc B, Leprince J, Anouar Y, Chartrel N, Picot M.
    BMJ Open Diabetes Res Care; 2020 Feb 01; 8(1):. PubMed ID: 32114486
    [Abstract] [Full Text] [Related]

  • 8. The Neuropeptide 26RFa (QRFP) and Its Role in the Regulation of Energy Homeostasis: A Mini-Review.
    Chartrel N, Picot M, El Medhi M, Arabo A, Berrahmoune H, Alexandre D, Maucotel J, Anouar Y, Prévost G.
    Front Neurosci; 2016 Feb 01; 10():549. PubMed ID: 27965532
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The 26RFa (QRFP)/GPR103 Neuropeptidergic System: A Key Regulator of Energy and Glucose Metabolism.
    Devère M, Takhlidjt S, Prévost G, Chartrel N, Leprince J, Picot M.
    Neuroendocrinology; 2024 Apr 10; ():1-17. PubMed ID: 38599200
    [Abstract] [Full Text] [Related]

  • 11. RFamide peptides 43RFa and 26RFa both promote survival of pancreatic β-cells and human pancreatic islets but exert opposite effects on insulin secretion.
    Granata R, Settanni F, Trovato L, Gallo D, Gesmundo I, Nano R, Gallo MP, Bergandi L, Volante M, Alloatti G, Piemonti L, Leprince J, Papotti M, Vaudry H, Ong H, Ghigo E.
    Diabetes; 2014 Jul 10; 63(7):2380-93. PubMed ID: 24622796
    [Abstract] [Full Text] [Related]

  • 12. The orexigenic activity of the hypothalamic neuropeptide 26RFa is mediated by the neuropeptide Y and proopiomelanocortin neurons of the arcuate nucleus.
    Lectez B, Jeandel L, El-Yamani FZ, Arthaud S, Alexandre D, Mardargent A, Jégou S, Mounien L, Bizet P, Magoul R, Anouar Y, Chartrel N.
    Endocrinology; 2009 May 10; 150(5):2342-50. PubMed ID: 19164468
    [Abstract] [Full Text] [Related]

  • 13. 26RFa, a novel orexigenic neuropeptide, inhibits insulin secretion in the rat pancreas.
    Egido EM, Hernández R, Leprince J, Chartrel N, Vaudry H, Marco J, Silvestre RA.
    Peptides; 2007 Apr 10; 28(4):725-30. PubMed ID: 16777265
    [Abstract] [Full Text] [Related]

  • 14. VGF ablation blocks the development of hyperinsulinemia and hyperglycemia in several mouse models of obesity.
    Watson E, Hahm S, Mizuno TM, Windsor J, Montgomery C, Scherer PE, Mobbs CV, Salton SR.
    Endocrinology; 2005 Dec 10; 146(12):5151-63. PubMed ID: 16141392
    [Abstract] [Full Text] [Related]

  • 15. The Arg-Phe-amide peptide 26RFa/glutamine RF-amide peptide and its receptor: IUPHAR Review 24.
    Leprince J, Bagnol D, Bureau R, Fukusumi S, Granata R, Hinuma S, Larhammar D, Primeaux S, Sopkova-de Oliveiras Santos J, Tsutsui K, Ukena K, Vaudry H.
    Br J Pharmacol; 2017 Oct 10; 174(20):3573-3607. PubMed ID: 28613414
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The RFamide neuropeptide 26RFa and its role in the control of neuroendocrine functions.
    Chartrel N, Alonzeau J, Alexandre D, Jeandel L, Alvear-Perez R, Leprince J, Boutin J, Vaudry H, Anouar Y, Llorens-Cortes C.
    Front Neuroendocrinol; 2011 Oct 10; 32(4):387-97. PubMed ID: 21530572
    [Abstract] [Full Text] [Related]

  • 18. Negative regulation of hepatic fat mass and obesity associated (Fto) gene expression by insulin.
    Mizuno TM, Lew PS, Luo Y, Leckstrom A.
    Life Sci; 2017 Feb 01; 170():50-55. PubMed ID: 27914922
    [Abstract] [Full Text] [Related]

  • 19. Differential effects of angiotensin receptor blockers on pancreatic islet remodelling and glucose homeostasis in diet-induced obese mice.
    Graus-Nunes F, Marinho TS, Barbosa-da-Silva S, Aguila MB, Mandarim-de-Lacerda CA, Souza-Mello V.
    Mol Cell Endocrinol; 2017 Jan 05; 439():54-64. PubMed ID: 27780713
    [Abstract] [Full Text] [Related]

  • 20. Marked improvement of glucose homeostasis in diabetic ob/ob mice given oral vanadate.
    Brichard SM, Bailey CJ, Henquin JC.
    Diabetes; 1990 Nov 05; 39(11):1326-32. PubMed ID: 2227106
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.